An interventional study of MyHealthPath Tool and MyHealthPath Guide in Obesity, sponsored by University of Florida. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-06.
Sponsored by University of Florida · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 37 studies in Obesity by University of Florida — 5 open to participants now, 6 under way, none of them phase 3. Obesity · University of Florida.
Among the 37 studies in Obesity by University of Florida, this one has the largest planned enrollment of the 34 interventional ones that give a count, is one of 4 that started in 2024, is one of 29 with no phase, and was the 32nd registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →5 of the 37 studies in Obesity by University of Florida are open now, in 1 country. Recruiting first, the newest first:
University of Florida · Sites in United States
Ages 25+ · Women only · Healthy volunteers
University of Florida · Sites in United States
Ages 18+
University of Florida · Sites in United States
Ages 30–79
University of Florida · Sites in United States
Ages 13–17
By country, each count listing its studies:
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
37 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 4 1
First in 2003; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 864 is above the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 55 across the 34 interventional studies, 392 across the 3 observational. Of the 31 that completed or were terminated, 13 (42%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Florida is the lead sponsor of 1,290 studies on the registry; 202 are open to participants now.
Of its 181 completed or terminated interventional studies of FDA-regulated products, 143 (79%) have results posted.
2 of the studies in Obesity by University of Florida that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05561595University of FloridaTransdiagnostic Intervention to Reduce Internalized Health-Related Stigma | 2026-12-31 |
| NCT07714759University of FloridaA Study Comparing Continuous Glucose Monitoring Augmented Nutritional Counseling and Standard of Care Treatment Strategies in a Three-Month Nutrition Intervention | 2027-08 |
Add all 2 to your calendar (.ics) → With an account.
Among the 37 studies in Obesity by University of Florida, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will test the effects of a brief, individually tailored intervention aiming to increase initiation of comprehensive behavioral weight loss treatment on weight.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Receive MyHealthPath Tool intervention.
Behavioral: MyHealthPath Tool
Receive MyHealthPath Guide intervention
Behavioral: MyHealthPath Guide
Tailored, brief online tool to help patients learn about weight treatment options
Informational material to help patients learn about weight treatment options
Proportion initiating treatment
Attend at least one intervention session of comprehensive behavioral weight loss intervention. Documented by interventionist/program.
Time frame: Within 2 months of PCP appointment date
Number of treatment sessions attended
Total number of attended intervention session of comprehensive behavioral weight loss intervention. Documented by interventionist/program.
Time frame: 6 months
Proportion discussing weight-related topic with PCP
Per patient self-report, discussed weight, diet, or physical activity with PCP at index PCP visit.
Time frame: at completion of PCP visit (occuring up to 4 weeks after enrollment)
Proportion achieving 5% weight loss
Proportion of participants losing 5% of their baseline weight between baseline and 6 months
Time frame: 6 months
Percent weight loss
Percent weight loss from baseline to 6 months
Time frame: 6 months
Plan to share: Yes — De-identified individual data will be shared with other researchers. Researchers may need to complete a data use authorization agreement.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code
Time frame: Data will be available within one year of study completion and remain available indefinitely.
Access criteria: Access will be granted to researchers for any scientific purpose, including verifying/replicating analyses or conducting additional analyses, or
Started Jan 2024 (actual). Primary completion is estimated for Apr 2028, 51 months after the start.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 51 months is above that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.